Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03891654 · ClinicalTrials.gov registry record · Early Phase 1

Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients

A Early Phase 1 study, sponsored by University of Colorado, Denver.

Completed
Registry status
Early Phase 1
Development phase
3
Enrollment target

NCT03891654 is a Early Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03891654, a Early Phase 1 study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
Early Phase 1
Development phase
3 participants
Enrollment target

Study Summary

This is a pilot study that uses a standard of care technique, Stereotactic Body Radiation Therapy (SBRT), in combination with Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to determine if perfusion changes from SBRT of liver cancer may be used for outcome assessment and prediction of prognosis.

Interventions

  • DIAGNOSTIC_TEST Dynamic Contrast Enhanced Computed Tomography

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2019-08-01
Est. Completion 2022-04-28
Phase Early Phase 1

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT03891654

The ClinicalTrials.gov registry entry for NCT03891654 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dynamic Contrast Enhanced Computed Tomography is the first listed.

NCT03891654 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03891654 about?

NCT03891654 is a clinical study titled "Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients". This is a pilot study that uses a standard of care technique, Stereotactic Body Radiation Therapy (SBRT), in combination with Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to determine if perfusion changes from SBRT of liver cancer may be used for outcome assessment and prediction of progno...

What is the current status of trial NCT03891654?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2019-08-01. Estimated completion is 2022-04-28.

What interventions are being tested in trial NCT03891654?

The interventions under investigation include: Dynamic Contrast Enhanced Computed Tomography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03891654?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.